Gioksizon ointment 10g tube

Description

Composition
Active substance:
1 g of ointment contains hydrocortisone acetate – 10.0 mg, oxytetracycline hydrochloride – 30.0 mg ;.
Product form:
Ointment for local and external use.
Contraindications
Hypersensitivity, lupus, skin tumors, precancerous lesions, athlete’s foot, viral skin diseases (herpes, chickenpox); pregnancy, lactation (when applied to extensive lesions).
Indications
Neonatal dermatitis (cystic and exfoliative) infected intertrigo, folliculitis, furunculosis, carbuncle, impetigo, erysipelas; infected eczema and wounds, erosion; urticaria of the newborn; simple and allergic dermatitis, seborrhea; “Solar” erythematous rash; erythema multiforme; insect bites; purulent diseases and allergic external auditory meatus; varicose leg ulcers, burns, frostbite.
Interaction with other drugs
Cases interaction or incompatibility described with other drugs.
Overdose
About the cases of drug overdose gioksizon ointment has not been reported.
pharmachologic effect
Pharmacological group:
Glucocorticosteroids for local use + antibiotic tetracycline.
Pharmacological properties:
Combined preparation inhibits the development of inflammatory reactions of the skin, especially of allergic origin, complicated by bacterial infection, resulting in the total effect of the components included in the formulation. Oxytetracycline – an antibiotic of the tetracycline group, has a bacteriostatic effect. Active against gram-positive and gram-negative bacteria, Rickettsia spp., Treponema spp., Chlamydia spp., Mycoplasma spp. Hydrocortisone – glucocorticosteroid, anti-inflammatory, anti-allergic, anti-exudative and antipruritic effects. Inhibits phagocytosis; reducing the synthesis of prostaglandins and leukotrienes by inhibiting the activity of phospholipase A2 and reduce the release of arachidonic acid from phospholipids of cell membranes. Inhibits release of interleukins and other cytokines that cause inflammation.; inhibits the release of histamine and the emergence of local allergic reactions. Reduces protein synthesis and deposition of collagen in the skin, prevents the development of connective tissue, weakens proliferative processes.
Conditions of supply of pharmacies
On prescription.
side effects
Rare opportunity – allergic reactions, skin irritation, itching, rash. With prolonged use and / or applied to the large surfaces – systemic side effects of corticosteroids. When applied on the facial skin – can telangiectasias, atrophy of subcutaneous tissue in the mouth.
special instructions
During treatment with glucocorticosteroids (GCS) should not be vaccinated against smallpox and other immunization schedule (due to the immunosuppressive effect of corticosteroids).
Children should avoid applying the product to the extensive surface and under occlusive dressings.
If necessary, use in facial skin, the treatment should be short because of the increased suction and possibility of occurrence of side effects.
Storage conditions
At temperatures above 25 ° C.
Keep out of the reach of children.
Dosing and Administration
Locally, topically.
An ointment in an amount of 0.5-1 g applied thinly to the affected areas of skin 1-3 times a day, or under a sterile gauze bandage.
Duration of treatment is individual.
Information
Appearance may differ from that depicted in the picture. There are contraindications. You need to read the manual or consult with a specialist